Induction of labour in pre-eclamptic women: a randomised trial comparing the Foley balloon catheter with oral misoprostol

BMC Pregnancy and Childbirth

Andrew Weeks⁴  Beverly Winikoff³  Zarko Alfirevic⁴  Mark Turner⁴  Alan Haycox⁵  Thomas Easterling¹  Brian Faragher²  Shuchita Mundle⁶  Hillary Bracken³ 

[1] Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington 98195, USA;Medical Statistics, LSTM Clinical Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK;Gynuity Health Projects, 15 East 26th Street, Suite 801, New York, NY 10010, USA;Department of Women’s and Children’s Health, University of Liverpool, Liverpool Women’s Hospital, Crown Street, Liverpool, L8 7SS, UK;Department of Women’s and Children’s Health, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK;Department of Obstetrics & Gynecology, Government Medical College, Nagpur, 440003, India

关键词: Induction of labor;    Foley catheter;    Misoprostol;    Preeclampsia;   

Others  :  1125524
DOI  :  10.1186/1471-2393-14-308

 received in 2014-05-29, accepted in 2014-07-09,  发布年份 2014

【 摘 要 】

Background

Between 40,000 and 80,000 pregnant women die annually from pre-eclampsia and eclampsia. Although magnesium sulphate and anti-hypertensive therapies can reduce the morbidity and mortality associated with pre-eclampsia, the only cure comes with delivery. Prompt delivery of the baby, preferably by vaginal route, is vital in order to achieve good maternal and neonatal outcomes. Induction of labour is therefore a critical intervention in order to prevent morbidity to both mother and baby. Two low cost interventions – oral misoprostol tablets and transcervical Foley catheterization – are already used by some in low resource settings, but their relative risks and benefits are not known. The trial will compare the risks, benefits, and trade-offs in efficacy, safety, acceptability and cost of misoprostol and Foley catheter for induction in women with preeclampsia or uncontrolled hypertension.

Methods/Design

A total of 602 women with an ongoing pregnancy with a live fetus requiring delivery because of pre-eclampsia or uncontrolled hypertension will be randomly assigned to labor induction with a transcervical Foley catheter or oral misoprostol 25 micrograms. Women will be recruited at two hospitals in Nagpur, India. The misoprostol group will receive oral misoprostol 25 microgram every 2 hours for a maximum of 12 doses or until active labor commences. The Foley group will undergo induction using a Foley catheter (silicone, size 18 F with 30 ml balloon) which will remain until active labor starts, the Foley catheter falls out, or 12 hours have elapsed. The primary outcome will be the attainment of vaginal delivery within 24 hours. Providers administering the treatment and those assessing the outcomes will not be blinded to group assignment.

Trial registration

NCT01801410 (ClinicalTrials.gov).

【 授权许可】

   
2014 Bracken et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-1074. Review. PubMed PMID: 16581405
• [2]Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D: Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefitfrom magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002, 359(9321):1877-1890.
• [3]Duley L, Meher S, Jones L: Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013, 7:CD001449. doi:10.1002/14651858.CD001449.pub3. Review.PubMed PMID: 23900968
• [4]Alfirevic Z, Weeks A: Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2006, (2):CD001338. doi:10.1002/14651858.CD001338.pub2
• [5]Hofmeyr GJ, Gülmezoglu AM, Pileggi C: Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010, (10):CD000941. doi:10.1002/14651858.CD000941.pub2
• [6]Kundodyiwa TW, Alfirevic Z, Weeks AD: Low-dose oral misoprostol for induction of labor: a systematic review. Obstet Gynecol 2009, 113:374-383.
• [7]Jozwiak M, Oude Rengerink K, Benthem M, van Beek E, Dijksterhuis MG, de Graaf IM, van Huizen ME, Oudijk MA, Papatsonis DN, Perquin DA, Porath M, van der Post JA, Rijnders RJ, Scheepers HC, Spaanderman ME, van Pampus MG, de Leeuw JW, Mol BW, Bloemenkamp KW, PROBAAT Study Group: Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial. Lancet 2011, 378(9809):2095-2103. doi:10.1016/S0140-6736(11)61484-0. Epub 2011 Oct 24.PubMed PMID: 22030144
• [8]Jozwiak M, Bloemenkamp KWM, Kelly AJ, Mol BWJ, Irion O, Boulvain M: Mechanical methods for induction of labour. Cochrane Database Syst Rev 2012, (3):CD001233. doi:10.1002/14651858.CD001233.pub2
• [9]Pennell CE, Henderson JJ, O'Neill MJ, McCleery S, Doherty DA, Dickinson JE: Induction of labour in nulliparous women with an unfavourable cervix: a randomised controlled trial comparing double and single balloon catheters and PGE2 gel. BJOG 2009, 116:1443.
• [10]Yuen PM, Pang HYY, Chung T, Chang A: Cervical ripening before induction of labour in patients with an unfavourable cervix: a comparative randomized study of the Atad ripener device, prostaglandin E2 vaginal pessary, and prostaglandin E2 intracervical gel. Aus NZ J Obstet Gynecol 1996, 36:291-295.
• [11]Owolabi AT, Kuti O, Ogunlola IO: Randomised trial of intravaginal misoprostol and intracervical Foley catheter for cervical ripening and induction of labour. J Obstet Gynaecol 2005, 25:565-568.